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Metastasis into a thyroid neoplasm—tumor-to-tumor metastasis—is exceedingly rare. We describe the 28th documented case of
a tumor metastatic to a thyroid neoplasm and review the literature on tumor-to-tumor metastasis involving a thyroid neoplasm
as recipient. All cases showed a recipient thyroid neoplasm with an abrupt transition to a morphologically distinct neoplasm.
Metastasis into primary thyroid neoplasm was synchronous in 33% of cases and metachronous in 67%. Follicular adenoma was
the most common recipient thyroid neoplasm overall (16/28), and papillary thyroid carcinoma was the most common malignant
recipient neoplasm (9/28). Of the 9 recipient papillary carcinomas, 6 were follicular variants. Renal cell carcinoma was the most
common neoplasm to metastasize to a primary thyroid neoplasm (9/28), followed by lung (6/28), breast (5/28), and colon (3/28)
carcinoma. Tumor-to-tumor metastasis should be considered whenever a dimorphic pattern is encountered in a thyroid tumor.
1.Introduction
Metastasis to thyroid gland is uncommon, with reported
incidences ranging from 0.5% [1] in unselected autopsy
studies to as high as 24% [2, 3] in those with widespread
metastatic disease. Malignant melanoma and carcinomas
of lung, breast, kidney, gastrointestinal tract, and head
and neck, among many other tumors, have been noted to
secondarily involve the thyroid gland [1–4]. Metastasis to a
primary thyroid neoplasm is extremely rare, however. To our
knowledge, only 27 cases of tumor-to-tumor metastasis in
which the recipient tumor was a primary thyroid neoplasm
have been reported in the literature [3–23]. We report a case
of poorly diﬀerentiated carcinoma of lung metastatic to a
follicular adenoma and review the literature on tumor-to-
tumor metastasis in the thyroid gland.
2.CaseReport
A 65-year- old white male with coronary artery disease
presented to medical attention with shortness of breath.
Imaging studies revealed a mass in the right upper lobe
of lung, and a right upper lobectomy was performed. A
peripherally located 5.5 × 5.0 × 4.5cm irregular tan-white
tumor causing pleural retraction was noted. Histologic exam
revealed an invasive tumor arranged predominantly in nests
and islands with abundant central necrosis (Figure 1(a)). A
microscopicfocus ofglandularpatternwas identiﬁed, butno
deﬁnite squamous diﬀerentiation was seen. Cytologically the
neoplasticcellshadamoderateamountofamphophiliccyto-
plasm and enlarged hyperchromatic nuclei with vesicular to
coarse chromatin and inconspicuous nucleoli (Figure 1(b)).
Greater than 5 mitotic ﬁgures per high power ﬁeld were
noted. The tumor did not invade the visceral pleura. Several
immunoperoxidase stains were performed using a stan-
dard streptavidin-biotin-peroxidase method to elucidate the
tumordiﬀerentiation.The carcinoma cellsshowed focal pos-
itivity forcytokeratin7andcytokeratin34betaE12,butwere
negative for cytokeratin 5/6, p63, TTF-1, chromogranin,
synaptophysin, andCD56immunostains. Mucicarminestain
revealed no evidence of mucin production. A diagnosis of
poorlydiﬀerentiatedcarcinomaoflungwithbasaloidpattern2 Pathology Research International
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Figure 1: (a) Low power (20x; H & E) photomicrograph demon-
strating invasive lung tumor arranged in nests and islands with
abundant central necrosis. Cytologically (b) the malignant cells
displayed enlarged, hyperchromatic nuclei with vesicular to coarse
chromatin and a moderate amount of amphophilic cytoplasm
(200x; H & E).
was made. Oneregional lymph nodeand inferior pulmonary
ligament tissue were involved by metastatic carcinoma.
Postoperative tumor staging by positron emission
tomography (PET) scan revealed an area of increased uptake
in the right thyroid lobe (standardized uptake value: 64).
Serum thyroid stimulating hormone (TSH), thyroxine, and
calcitoninlevelswere notperformed. Ultrasound guidedﬁne
needle aspiration of the thyroid lesion showed numerous
microfollicles and scant colloid, consistent with a follicular
neoplasm. No evidence of metastatic pulmonary poorly dif-
ferentiated carcinoma was identiﬁed in the thyroid aspirate.
A total thyroidectomy was performed approximately 8weeks
followingthediagnosisoftheprimary lungcarcinoma.Gross
examination revealed a 36-gram thyroid gland with a 4.5 ×
3.2 × 3.0cm tan-brown encapsulated nodule in the right
lobe. Within this nodule were multifocal irregular white-
tan lesions (Figure 2(a)). Histologic exam of the nodule
revealed a follicular adenoma with microfollicular and
trabecular architecture; no capsular or vascular invasion was
identiﬁed. Within the follicular adenoma were multifocal
areas showing an abrupt transition to a morphologically
distinct neoplasm comprised of cells with enlarged, hyper-
chromatic nuclei arranged in rounded nests with abundant
central necrosis (Figure 2(b)). This tumor in the follicular
adenoma was cytomorphologically identical to the patient’s
lung carcinoma (Figure 2(c)). Metastatic tumor emboli were
also present in the intracapsular vessels of the follicular
adenoma. Immunoperoxidase stains ofthese cells were nega-
tive for thyroglobulin (Figure 2(d)), calcitonin, and thyroid
transcription factor (TTF-1). This metastatic carcinoma
did not involve the nonneoplastic thyroid gland. Poorly
diﬀerentiated carcinoma of lung metastatic to a follicular
adenoma was diagnosed. There was no evidence of tumor in
the left thyroid lobe.
In addition, a 4.0 × 3.9 × 3.0cm subcutaneous right
chest wall mass excised at the time of thyroidectomy
was completely replaced by metastatic poorly diﬀerentiated
carcinoma of lung.
3.Discussion
Criteria used in diagnosing tumor-to-tumor metastasis
require that the recipient tumor is a true neoplasm and that
the donor neoplasm is a true metastasis, that is, invasion
into the substance of recipient neoplasm is proven, with
the caveat that the presence of only tumor emboli within
a recipient neoplasm does not qualify as a true tumor-to-
tumor metastasis [3, 19, 24]. Collision tumor, contiguous
growth of one neoplasm into another adjacent neoplasm,
and metastasis to a lymph node already involved by lym-
phoreticular malignancy are also excluded [19, 24]. Our case
of poorly diﬀerentiated carcinoma of lung metastatic to a
follicular adenoma meets these criteria of a true tumor-
to-tumor metastasis. Deﬁned in this way, approximately
150 case reports of tumor-to-tumor metastasis exist in
the literature [22, 25]. Renal cell carcinoma, meningioma,
and thyroid neoplasms are frequent recipients in tumor-
to-tumor metastasis [22, 25, 26]. Common donor tumors
in tumor-to-tumor metastasis include carcinomas of lung,
breast, stomach, prostate, and thyroid, among others [25].
This is the 28th case reported in which a thyroid
neoplasm served as the recipient tumor in a tumor-to-
tumor metastasis. In all cases an abrupt transition to a
morphologically distinct neoplasm was noted. Of these 28
cases, the recipient thyroid neoplasm was benign in 16 cases
(follicular adenoma) ([4–8, 10–12, 15, 17–19, 23],and the
present case) and malignant in 12 cases [3, 4, 9, 13, 14, 16,
20–22]. Of the 12 malignant recipient thyroid neoplasms,
there were 9 papillary carcinomas [3, 4, 9, 20–22]( 6o f
which were follicular variants of papillary carcinoma [9,
21, 22]) and 3 follicular carcinomas [13, 14, 16]( 2o f
Hurthle cell type [13, 14] ) .R e n a lc e l lc a r c i n o m aw a st h e
most common donor neoplasm metastasizing to a primary
thyroid neoplasm (9 cases) [3–5, 9, 12, 13, 15, 17, 22]
followed by lung carcinoma (6 cases, including the present
case) [6, 8–10, 20], breast carcinoma (5 cases, including
one inﬁltrating lobular carcinoma) [4, 7, 18, 21, 22], and
colon carcinoma (3 cases) [10, 14, 19]. Isolated single cases
of prostate adenocarcinoma [7], melanoma [16], pancreaticPathology Research International 3
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Figure 2: (a) An encapsulated tan-brown adenoma was present within the right thyroid lobe with multifocal white-tan areas within the
adenoma (arrows). Within the encapsulated follicular adenoma is an abrupt transition to a morphologically distinct neoplasm (asterisk)
(40x;H&E)(b).Metastaticcarcinoma(asterisk)wasarrangedinnestswithenlargedvesicularnucleiwithinconspicuousnucleoliinﬁltrating
the follicularadenoma(200x;H & E) (c). The metastaticcarcinomawas negative forthyroglobulin, while the adenomawas stronglypositive
(100x; IHC) (d).
neuroendocrine carcinoma [9], Burkitt-like lymphoma [23],
and a malignant Phyllodes tumor [11] have also been
reported to metastasize to a primary thyroid neoplasm. In
two cases the donor malignancy remained clinically occult
until it metastasized to a primary thyroid neoplasm (colonic
adenocarcinoma [19] and renal cell carcinoma [5], both
metastatic to follicular adenoma). In two cases diagnosis of
a tumor-to-tumor metastasis was established at the time of
ﬁne needle aspiration based on the dimorphic appearance of
the sample, one a breast carcinoma metastatic to a follicular
variant of papillary carcinoma [21] and the other a renal
cell carcinoma metastatic to an oncocytic carcinoma [13].
Women outnumbered men in this series (16 women; 10
men; two cases did not specify sex), and the average age
at presentation of tumor-to-tumor metastasis was 59.2years
(age range 38–82years).
The interval between diagnosis of primary tumor and its
metastasis into a thyroid neoplasm was noted in 24 cases ([3,
5–19, 22, 23], and the present case). Diagnosis of primary
tumor and its metastasis into a thyroid neoplasm were
synchronous in 8/24(33%)casesand metachronous in16/24
(67%) cases (interval range of 2months–10years). In 13
cases, presence or absence of metastasis into nonneoplastic
thyroid gland could be ascertained from the case reports
([3, 6, 9, 10, 13, 15, 19, 22], and the present case). In 10
of these cases (10/13; 77%), metastasis was conﬁned to the
primary thyroid neoplasm. Presence or absence of metastasis
to tissue other than the thyroid gland could be determined
in 20 cases ([3, 6, 7, 9–11, 13, 14, 16–19, 22, 23], and
the present case), seventeen of which (17/20; 85%) also
showed metastasis of donor tumor to anatomic locations
other than the thyroid gland. Outcome after diagnosis of
tumor-to-tumor metastasis was available in 15 cases ([3, 5–
7, 9–11, 17, 19, 22, 23], and the present case). Five of these
(5/15)patientsdiedatthetimeof,orshortlyafter,thetumor-
to-tumor metastasis, and 1 patient (1/15) died 2years after
diagnosis of tumor-to-tumor metastasis. 9/15 patients were
alive at the time of the case reports.
Neoplastic thyroid gland may be fertile “soil” for tumor
metastasis due to decreases in oxygen concentration, altered
iodine content, and the rich vascularity associated with
neoplasia [3] .T u m o rm e t a s t a s i si sv e r yc o m p l e x ,a n dt u m o r -
to-tumormetastasis islikelyevenmore so, and thesetheories
are probably only part of a complex mechanism that at
present is poorly understood.
Tumor-to-tumor metastasis should be considered when-
ever a distinct, dimorphic pattern is encountered in a
tumor [19, 25]. When a component of poorly diﬀerentiated
carcinoma is present in the thyroid in association with a
follicular patterned lesion, as occurred in this case, the dif-
ferential diagnosis would include thyroid carcinoma arising
in association with a follicular adenoma, insular carcinoma
(poorly diﬀerentiated thyroid carcinoma), glandular variant
of medullary carcinoma, the rare mixed medullary and
follicular composite tumor, mucoepidermoid carcinoma,
contiguous spread from carcinomas of adjacent pharynx,
l a r y n x ,t r a c h e a ,o re s o p h a g u s ,a n dm e t a s t a s i s[ 4, 7, 9, 27].4 Pathology Research International
Colon carcinoma metastatic to the thyroid gland and colum-
nar cell carcinoma of the thyroid must be distinguished from
one another [28]. Metastatic carcinoma within the thyroid
gland is negative for thyroglobulin and calcitonin [4, 7].
Thyroid transcription factor-1 (TTF-1) has little value in
the diﬀerential diagnosis of lung carcinoma metastatic to
thyroid versus a primary thyroid carcinoma, as both are
oftenpositive[20].Similarly,bothmetastaticlungcarcinoma
and glandular variant of medullary carcinoma can be CEA
positive. Metastatic breast carcinoma can be ER and PR
positive, but will be thyroglobulin and calcitonin negative
[7, 18]. As in the present case, careful attention to clinical
history, the dimorphic histologic appearance, comparison
with prior surgical material, and immunohistochemistry
for thyroglobulin, TTF-1, and calcitonin can be helpful in
arriving at a correct diagnosis.
Before diagnosing renal cell carcinoma metastatic to the
thyroid gland, primary thyroid lesions that can show clear
cell change should be excluded [4]. These include primary
thyroid tumors such as follicular neoplasms (Hurthle cell
type and otherwise), papillary carcinoma, medullary carci-
noma,andparaganglioma. Attentiontoclinicalhistory, pres-
ence of multifocal growth pattern, optically clear rather than
granular cytoplasm, a sinusoidal pattern of vascularization,
and positivity for CD10,renal cell carcinoma antigen (RCC),
and vimentin, and negativity for TTF-1 and thyroglobulin,
favor a diagnosis of metastatic renal cell carcinoma [3, 5, 17].
Other secondary tumors with clear cell features should also
be excluded, including those arising from the lung and
salivary gland tissue. Distinction of a primary tumor from
metastasis can be diﬃcult without histologic comparison
with prior specimen. Some have used DNA ploidy, loss of
heterozygosity (LOH) analysis of the von Hippel-Lindau
(VHL) gene locus, and Ras mutation status as adjuncts to
diagnosing tumors metastatic to thyroid [7, 22]. Presence of
Ras mutation favors a primary thyroid follicular neoplasm
o v e rm e t a s t a t i cr e n a lc e l lc a r c i n o m a .L o s so fV H Lg e n el o c u s
favors a diagnosis of metastatic renal cell carcinoma over a
primary thyroid neoplasm with clear cell change [22].
This paper reviews the 27 reported cases of a thyroid
neoplasm serving as recipient in a tumor-to-tumor metas-
tasis and describes the 28th such case, a poorly diﬀerentiated
carcinoma of lung metastatic to a follicular adenoma. It is
important to note, however, that even in patients with a
clinical history of malignancy a new thyroid nodule is still
likely to be a benign lesion [17]. While metastatic tumors
in the thyroid gland are relatively uncommon, tumors
metastatic to other thyroid neoplasms are extremely rare.
Clinicalhistory ofpriormalignancy, presenceofadimorphic
cell population, and comparison with prior surgical material
is useful in diagnosing tumor-to-tumor metastasis involving
the thyroid gland as recipient. This review of 28 examples of
a thyroid neoplasm serving as recipient tumor in a tumor-
to-tumor metastasis indicates that follicular adenoma is the
most common recipient thyroid neoplasm (16/28cases), and
papillarycarcinomaisthemostcommonmalignantrecipient
thyroid neoplasm (9/28 cases). Renal cell carcinoma, lung,
and breast carcinomas are the most common neoplasms to
metastasize to a thyroid neoplasm.
References
[1] K. Y. Lam and C. Y. Lo, “Metastatic tumors of the thyroid
gland: a study of 79 cases in Chinese patients,” Archives of
Pathology and Laboratory Medicine, vol. 122, no. 1, pp. 37–41,
1998.
[2] M. K. Nakhjavani, H. Gharib, J. R. Goellner, and J. A. Van
Heerden, “Metastasis to the thyroid gland: a report of 43
cases,” Cancer, vol. 79, no. 3, pp. 574–578, 1997.
[3] O. L. Bohn, L. E. de las Casas, and M. E. Leon, “Tumor-to-
tumor metastasis: renal cell carcinoma metastatic to papillary
carcinoma of thyroid-report of a case and review of the
literature,” Head and Neck Pathology, vol. 3, no. 4, pp. 327–
330, 2009.
[ 4 ]J .R o s a i ,M .L .C a r c a n g i u ,a n dR .D e L e l l i s ,Tumors of the
Thyroid Gland, 3rd series, fascicle 5, Armed Forces Institute
of Pathology, Washington,DC, USA, 1992.
[5] M. S. Chacho, E. Greenebaum, H. F. Moussouris,K. Schreiber,
and L. G. Koss, “Value of aspiration cytology of the thyroid in
metastaticdisease,”ActaCytologica,vol.31,no.6,pp.705–712,
1987.
[6] Y. Mizukami, K. Saito, A. Nonomura et al., “Lung carcinoma
metastatic to microfollicular adenoma of the thyroid. A case
report,” Acta Pathologica Japonica, vol. 40, no. 8, pp. 602–608,
1990.
[7] J. Y. Ro, C. Guerrieri, A. K. H. Naggar, N. G. Ordonez, J. G.
Sorge, and A. G. Ayala, “Carcinomas metastatic to follicular
adenomas of the thyroid gland: report of two cases,” Archives
of Pathology and Laboratory Medicine, vol. 118, no. 5, pp. 551–
556, 1994.
[8] H. Akamatsu, J. Amano, A. Suzuki, and Y. Kikushima, “A case
of micro-metastatic lung adenocarcinoma into adenoma of
the thyroid,” Kyobu geka, vol. 47, no. 4, pp. 319–321, 1994.
[9] Z.W.BalochandV.A.LiVolsi,“Tumor-to-tumormetastasisto
follicular variant of papillary carcinoma of thyroid,” Archives
of Pathology and Laboratory Medicine, vol. 123, no. 8, pp. 703–
706, 1999.
[10] K. Kameyama, N. Kamio, H. Okita, and J. I. Hata, “Metastatic
carcinoma in follicular adenoma of the thyroid gland,”
Pathology Research and Practice, vol. 196, no. 5, pp. 333–336,
2000.
[ 1 1 ]T .G i o r g a d z e ,R .M .W a r d ,Z .W .B a l o c h ,a n dV .A .L i V o l s i ,
“Phyllodes tumor metastatic to thyroid H¨ urthle cell adenoma:
an unusual tumor-to-tumor metastasis,” Archives of Pathology
and Laboratory Medicine, vol. 126, no. 10, pp. 1233–1236,
2002.
[12] G. Wolf, R. M. Aigner, U. Humer-Fuchs, T. H. Schwarz,
P. Krippl, and M. Wehrschuetz, “Metastasis of a renal cell
carcinoma in a microfollicularadenoma ofthe thyroid gland,”
Acta Medica Austriaca, vol. 29, no. 4, pp. 141–142, 2002.
[13] A. Ryˇ ska and J. ˇ C´ ap, “Tumor-to-tumor metastasis of renal cell
carcinoma into oncocytic carcinoma of the thyroid: report of
a case and review of the literature,” Pathology Research and
Practice, vol. 199, no. 2, pp. 101–106, 2003.
[14] R. L. Witt, “Colonic adenocarcinoma metastatic to thyroid
H¨ urthle cell carcinoma presenting with airway obstruction,”
Delaware Medical Journal, vol. 75, no. 8, pp. 285–288, 2003.
[ 1 5 ]L .Q i a n ,R .P u c c i ,C .Y .C a s t r o ,a n dM .A .E l t o r k y ,“ R e n a l
cell carcinomametastaticto H¨ urthle cell adenomaofthyroid,”
Annals ofDiagnosticPathology,vol.8,no.5,pp.305–308,2004.
[16] A. Terzi, K. Altundag, A. Saglam et al., “Isolated metastasis of
malignant melanoma into follicular carcinoma of the thyroidPathology Research International 5
gland,”JournalofEndocrinologicalInvestigation,vol.27,no.10,
pp. 967–968, 2004.
[17] H. L. Koo, J. Jang, S. J. Hong, Y. Shong, and G. Gong, “Renal
cell carcinoma metastatic to follicular adenoma of the thyroid
gland: a case report,” Acta Cytologica, vol. 48, no. 1, pp. 64–68,
2004.
[18] A. Peteiro, A. M. Duarte, and M. Honavar, “Breast carci-
noma metastatic to follicular adenoma of the thyroid gland,”
Histopathology, vol. 46, no. 5, pp. 587–588, 2005.
[ 1 9 ]O .F a d a r e ,V .P a r k a s h ,P .N .F i e d l e r ,A .B .M a y e r s o n ,a n d
B. Asiyanbola, “Tumor-to-tumor metastasis to a thyroid
follicular adenoma as the initial presentation of a colonic
adenocarcinoma,” Pathology International,v o l .5 5 ,n o .9 ,p p .
574–579, 2005.
[ 2 0 ]V .N a b i l i ,S .N a t a r a j a n ,S .H i r s c h o v i t z ,S .B h u t a ,a n dE .
Abemayor, “Collision tumor of thyroid: metastatic lung
adenocarcinoma plus papillary thyroid carcinoma,” American
Journal of Otolaryngology, vol. 28, no. 3, pp. 218–220, 2007.
[21] J. Yu, R. R. Seethala, A. Walls, and G. Cai, “Fine-needle
aspiration of breast carcinoma metastatic to follicular variant
ofpapillary thyroid carcinoma,”DiagnosticCytopathology,v ol.
37, no. 9, pp. 665–666, 2009.
[ 2 2 ]J .Y u ,M .N .N i k i f o r o v a ,S .P .H o d a ke ta l . ,“ T u m o r - t o - t u m o r
metastasesto follicularvariantofpapillary thyroid carcinoma:
histologic, immunohistochemical, and molecular studies of
two unusual cases,” Endocrine Pathology, vol. 20, no. 4, pp.
235–242, 2009.
[23] A. Camera, F. Magri, R. Fonte et al., “Burkitt-like lymphoma
inﬁltrating a hyperfunctioning thyroid adenoma and present-
ing as a hot nodule,” Thyroid, vol. 20, no. 9, pp. 1033–1036,
2010.
[24] L. V. Campbell, E. Gilbert, C. R. Chamberlain, and A. L.
Watne, “Metastases of cancer to cancer,” Cancer, vol. 22, no.
3, pp. 635–643, 1968.
[25] C. Petraki, M. Vaslamatzis, T. Argyrakos et al., “Tumor to
tumor metastasis: report of two cases and review of the
literature,” International Journal of Surgical Pathology, vol. 11,
no. 2, pp. 127–135, 2003.
[26] A.SellaandJ.Y.Ro,“Renalcellcancer:bestrecipient oftumor-
to-tumor metastasis,” Urology, vol. 30, no. 1, pp. 35–38, 1987.
[27] Z. W. Baloch and V. A. LiVolsi, “Neuroendocrine tumors of
the thyroid gland,” American Journal of Clinical Pathology,v o l .
115, pp. S56–S67, 2001.
[ 2 8 ]J .A .F e r r e i r o ,I .D .H a y ,a n dR .V .L l o y d ,“ C o l u m n a rc e l l
carcinoma of the thyroid: report of three additional cases,”
Human Pathology, vol. 27, no. 11, pp. 1156–1160, 1996.